Close

ULGX Financial Facts

Net loss per common share - basic (in dollars per share): -0.02
Gross profit: 1.31M
See Full Income Statement

COMMITMENTS AND CONTINGENCIES (Note 13): 0
Accrued compensation: 371K
See Full Balance Sheet

Urologix, Inc. (ULGX) Earnings

  |   Expand Research on ULGX
Next EPS Date 5/15/24 EPS Growth Rate N/A
Average EPS % Beat Rate +4.2% Revenue Growth Rate N/A
Average % Move 1-Wk after EPS 0.0% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
5/15/24 Q124 N/AN/A N/A N/AN/A N/A N/A N/A
2/9/24 Q423 N/AN/A N/A N/AN/A N/A N/A N/A
2/12/24 Q423 N/AN/A N/A N/AN/A N/A N/A N/A
2/26/24 Q423 N/AN/A N/A N/AN/A N/A N/A N/A
2/19/24 Q423 N/AN/A N/A N/AN/A N/A N/A N/A
11/1/23 Q323 N/AN/A N/A N/AN/A N/A N/A N/A
11/6/23 Q323 N/AN/A N/A N/AN/A N/A N/A N/A
11/13/23 Q323 N/AN/A N/A N/AN/A N/A N/A N/A